APA

Paulson D. M., Kennedy D. T., Donovick R. A., Carpenter R. L., Cherubini M., Techner L., Du W., Ma Y., Schmidt W. K., Wallin B. & Jackson D. (20050617). Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial. : The journal of pain.

Chicago

Paulson Daniel M, Kennedy Daniel T, Donovick Roger A, Carpenter Randall L, Cherubini Maryann, Techner Lee, Du Wei, Ma Yuju, Schmidt William K, Wallin Bruce and Jackson David. 20050617. Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial. : The journal of pain.

Harvard

Paulson D. M., Kennedy D. T., Donovick R. A., Carpenter R. L., Cherubini M., Techner L., Du W., Ma Y., Schmidt W. K., Wallin B. and Jackson D. (20050617). Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial. : The journal of pain.

MLA

Paulson Daniel M, Kennedy Daniel T, Donovick Roger A, Carpenter Randall L, Cherubini Maryann, Techner Lee, Du Wei, Ma Yuju, Schmidt William K, Wallin Bruce and Jackson David. Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial. : The journal of pain. 20050617.